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INTRODUCTION
Recent developments in genetic research suggest that it is possible to
decipher the complete sequence of human deoxyribonucleic acid ("DNA"),
the carrier of genetic information, which
will solve the puzzle of what makes
each individual human.I It is estimated
that 100,000 genes, discrete segments
of DNA, are found in the nucleus of
each human cell. 2 The knowledge derived from genetic research in discovering genetic abnormalities and possible cures will influence our lives
from fetus to the grave. The impact of
genetic research upon society is evident
considering that nearly 4,000 diseases
have a genetic component and approximately one out of ten individuals will
suffer from an inherited disease during
his lifetime.3
One of the applications of this genetic research is genetic testing in the
workplace. Employers and employees
will be consumers of a technology
which can benefit the workplace by
reducing occupational illness, 4 maintaining a safe workplace,' protecting
public safety,6 reducing insurance and
pension costs,7 and encouraging health
awareness among employees.8 Certainly, employers and employees will
want to avail themselves of these benefits - or will they?
Usually the controversy over any
new technology facing consumers is
not its benefits, but the application of
that technology to achieve those benefits. For example, how will employers use an employee's genetic test results? Will the employer dismiss an
employee summarily or refuse to hire a
job applicant because of a latent genetic
abnormality? Once an employer receives information about an individual's
genetic make-up, will other third par-

The knowledge derived from
genetic research in discovering
genetic abnormalities and
possible cures will influence our
lives from fetus to the grave.

ties be privy to that information? What
legal remedies are available to an employee if he is genetically discriminated against? To further complicate
things, will it matter that many genetic
abnormalities tend to fall along racial
and ethnic lines? These are just some of
the complex social, ethical, and legal
questions that consumers, employers,
and employees will face with genetic
testing in the workplace.
This article will focus on genetic
screening and how employers and employees, as consumers, will be affected
by this dynamic technology. Part I will
discuss basic genetic principles and the
market forces that invite consumers to
use genetic screening. Part II will
present the arguments why genetic
screening, as of yet, is not a viable
technology for the workplace. Part III
presents the circumstances under which
genetic screening is beneficial to consumers. Part IV will discuss the
government's role in regulation of
screening. Finally, Part V will review
what legal relief exists to remedy genetic discrimination.
I. GENES AND GENETIC TESTING
Individuals have twenty-three pairs
of chromosomes.9 Each chromosome
is composed of DNA, Segments of
DNA are the ultimate units of inheritance. A gene contains the code for the
production of proteins. A mutant gene
produces a defective corresponding
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protein. Whether a protein is present,
absent, or abnormally synthesized determines an individual's genetic makeup, including a genetic disease.'0
Genetic testing is a scientific technique that detects genetic traits, including changes in chromosomes or changes

.. The remarkable pace of
discovery in the genetic field has led
some to joke about "the gene of the
week."

in DNA." Currently, genetic testing is
capable of identifying individuals with
three types of genetic conditions: (1)
individuals who, due to genetic defects; have or will develop a genetic
disease; (2) individuals who carry, but
do not possess, a genetic disease; and
(3) individuals genetically predisposed
to disease in the future. 2 The first
category includes those who, for example, inherit the gene for cystic fibrosis, Huntington's disease, or Duchenne
muscular dystrophy. In each of these
examples, an individual with the defective gene cannot prevent the onset of
the disease by either preventive health
measures or a change of environment. '
Individuals in the second category
carry, but do not have, a genetic disease. However, these carriers can pass
the defective gene on to their children.
When both parents are carriers of the
defective gene, there is a high probability that their children will develop the
disease."'
Individuals in the third category are
susceptible to a genetic disease. The
genetic disease will not necessarily develop or even be likely to develop;
rather, if the individual leads a certain
lifestyle or exposes himself to a certain
environment, then the disease will or
will likely be expressed. 5
In the context of the workplace, two
types of genetic testing can occur:
screening and monitoring. 6 Genetic
screening is a one time test directed at
14

identifying individuals with particular
inherited traits or disorders. Monitoring, on the other hand, involves multiple tests of an individual over time to
determine whether workplace exposure has induced changes in the
individual's genetic make-up. 7
A. Evolution of Genetic Testing
Techniques
Before the development of recombinant DNA research, which is just
over a decade old, an individual's genetic composition could only be determined by his clinical appearance, family inheritance patterns, or indirect genetic tests. 8 Indirect genetic tests rely
upon detecting abnormal gene products which can be found in accessible
body fluid or tissue. The indirect tests
are ineffectual in determining genetic
abnormalities if no accessible fluid or
tissue is present to perform the tests. 9
Due to the development of recombinant DNA technology, we now have
tests that do not depend on either the
function or the product of the gene
because the tests examine the DNA
directly. Since DNA-based testing
examines an individual's DNA directly,
any accessible tissue on that person will
contain all the necessary genes to allow
the testing.2" Furthermore, DNA-based
testing will diagnose an abnormal gene
without knowledge of the gene's protein product. 21 Clearly, recombinant
DNA technology offers a much greater
opportunity to identify and diagnose
diseases with a genetic component than
do indirect genetic tests.
B. Genetic Testing in the Near
Future
Currently, there are few DNA-based
tests available on the market, with the
exceptions of the sickle cell anemia and
cystic fibrosis tests. 22 However, recombinant DNA research has uncovered an ever greater number of genes
capable of producing disease and has
identified genetic-environmental interactions which can cause predisposed
individuals to express a genetic illness. 3 The remarkable pace of discov-

ery in the genetic field has led some24to
joke about "the gene of the week."
Because of the advances in genetic
research, researchers are confident that
achieving the isolation of genetic mechanisms responsible for disease causation
or susceptibility will allow for more
genetic testing of individuals. 5 Government funding and commercial development will propel the explosion of
continued genetic research, leading to
26
more genetic testing.
1. Government funding
The United States Government has
approved and partially funded a fifteen
year study to chart the complete DNA
sequence of the human genome. The
human genome is "the chromosomal
collection each of us carries where
almost all human genes reside. 27 This
study, The Human Genome Initiative
("HGI"), will map the 100,000 genes
that comprise the human genome 28 and
is expected to use 30,000 years of labor
and to exceed a budget of $2 billion to
create genomic libraries encouraging
exchange of information between researchers. 29 This expected expenditure
of resources certainly places the project
among the most ambitious science undertakings of the past century.30
2. Commercial development
Market forecasting predicts that by
1992 there will be a $950-41,000 million market for genetic testing. 3' The
rivalry among biotechnology firms to
produce marketable diagnostic genetic
tests will be fierce due to the enormous
financial stakes.
An example that illustrates how biotechnology companies are in competition to produce diagnostic genetic tests
is the discovery of the cystic fibrosis

The rivalry among biotechnology
firms to produce marketable
diagnostic genetic tests will be
fierce due to the enormous financial
stakes.
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gene. Researchers discovered the genetic marker for cystic fibrosis in
1985.32 Later, in 1989, researchers
uncovered the actual cystic fibrosis
gene.33 As a result of the discovery,
several companies offered a genetic

[G]eneticscreening is not wholly
reliable in preventing or controlling
disease at the workplace since other
factors may influence the disease.

test to screen for cystic fibrosis. Controversy and concern over the reliability of the test caused the American
Society for Human Genetics to ask for
a voluntary moratorium of the test.
The companies that produced the test
34
agreed to the moratorium.
These companies did not agree to
the moratorium for altruistic reasons.
Rather, they agreed because of unpleasant memories surrounding genetic
testing for sickle cell anemia. When
these companies generated their test for
sickle cell anemia they miscounseled
tested individuals and mishandled test
results which caused confusion and
anxiety among the consumers. Many
individuals were wrongfully identified
as carriers of sickle cell or identified as
being affected by the disease. Because
of the unfavorable handling of this
genetic test, many companies now want
to get a favorable public response to
genetic testing to preserve the future
profits that the tests will generate.35
It is only a matter of time before
companies develop a media campaign
to create a favorable impression upon
consumers about genetic testing. The
issue then centers around whether the
interests of employers, persuaded to
use the tests, will be congruent with the
interests of employees. One significant
problem that employers and employees
will have with genetic screening is its
Volume 5 Number 1 / Fall 1992

reliability and validity. It is not uncommon for scientists to proclaim that
there is a consensus in their field about
the validity or reliability of a test, only
to discover new evidence demonstrating the unreliability of the test. Such
are the happenings of science, particularly in genetics, that cause consumers
to be skeptical about scientists and their
work.
II. ARGUMENTS OPPOSING THE
USE OF GENETIC SCREENING
A. Scientific Uncertainty
The common belief among the consumers is that genetic screening is very
reliable, highly accurate, and capable
of identifying an individual's predestined genetic future. The truth is that
the facts about genetic screening are
diametrically opposed to the common
perception. The results of genetic
screening are uncertain for many reasons.
Genetic screening assumes that, with
the exception of genetics, the workplace is the only other source for possible disease.36 In fact, nutrition, leisure time, and lifestyle activities may
well contribute to the expression of a
genetic disease in a predisposed individual. Therefore, genetic screening is
not wholly reliable in preventing or
controlling disease at the workplace
since other factors may influence the
disease.'
Genetic screening is deficient in
determining penetrance; that is, individuals who carry the gene may never
express the gene. Penetrance refers to
the frequency with which a gene expresses itself.3" When the gene does
express itself, its expression is variable; the degree of the gene's expression will vary from individual to individual.39 Because many genes, including defective genes, are characterized
by incomplete penetrance and variable
expression, there will be no basis for
knowing when the gene will express
itself and to what extent it will be
expressed. For example, Alzheimer's
disease may express itself early in a
person's life or much later in life.

I

To further compound the weaknesses
in the prediction of disease through
genetic screening, many individuals
who have a genetic disease can limit the
expression of the disease by behavioral
modification.' For example, modification of diet for those at risk of getting
diabetes or coronary heart disease can
prevent or significantly delay the
disease's occurrence.4 1
Since genetic screening tests have
poor predictive value in identifying
employees who may have a disabling
disease, genetic screening will have a
high false-positive rate. Due to its
inaccuracy, genetic screening should
not be used to determine if an employee
will be a threat to public safety. A more

It is only a matter of time before
companies develop a media
campaign to create a favorable
impression upon consumers about
genetic testing.

effective method of protecting the public is the use of routine examinations to
measure an employee' scapacity to function in ajob which poses a risk to public
safety.42 Further, routine functional
testing can detect an incapacity caused
by something other than the alleged
genetic disease.43
Arguably, genetic screening tests
are inaccurate, unreliable, and unpredictable in ascertaining the predetermined genetic future of an employee.
Presently, any employment decision
made by an employer on the basis of
inaccurate testing may be deemed an
irrational and arbitrary act.'
B. Genetic Screening and
Conf'dentiality
Genetic information about an individual is highly sensitive because it is
generally unchangeable. Therefore, if
a "flawed" gene is discovered using
15
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genetic screening, it "provides an ineradicable marker of deviance with
potentially lifelong social consequences
to the affected individual."45 Such
genetic information, if publicized, could
serve as the modem day scarlet letter,
stigmatizing an individual for life.
It is significant to note that many
employers have access to the medical
records of their employees through the
Medical Information Bureau ("MIB").6
The MIB serves as a clearinghouse that

The use ofgenetic screening inthe
workplace should only occur under
unusual circumstances and then
only with empirical data to support
the claim that genetic abnormalities
are occurring as a result of the

workplace.
allows insurers to exchange applicants'
medical history and test findings. Inadvertently, many employees disclose
their entire medical histories to the
MIB; when the employer requests medical information regarding an employee's
insurance claim, the employee discloses
an unnecessary amount of medical information to process the claim.47 Once
an employee allows any portion of his
medical history to be disclosed to an
employer who subscribes to the MIB,
the MIB and other insurers will have
access to the employee's medical history.
Obviously, an employee must be
very careful in providing medical information, especially genetic information, to an employer. Having an
agency like the MIB gather medical
information about individuals and provide that information to insurers is
discomforting. Even more discomforting is the fact that the MIB computerizes its data, making the information
susceptible to computer piracy." Piracy of computer data has occurred in
several private and public institutions.
It has been suggested that mandatory

disclosures of genetic information to
third parties be made illegal because of
the various problems in maintaining
confidentiality.49 It appears that more
stringent legal measures must be developed to protect the confidentiality of an
employee's genetic status.
III. APPROPRIATE GENETIC
SCREENING
Generally speaking, genetic screening is an unreliable diagnostic and prognostic indicator in determining which
workers are at an increased risk of
contracting a genetic disease. However, the validity and reliability of
genetic screening tests will improve as
more research is conducted by HGI and
private industry." Employers, as consumers, are motivated to use genetic
screening tests to help achieve the most
optimal "fit" in placing job applicants
and employees in those positions for
which they are best suited. In evaluating a "fit," employers may be motivated by concerns involving liability to
employees who are hypersusceptible to
certain workplace toxins, training costs
incurred on behalf of employees who
are unsuitable for a particular task,
costs resulting from sick leave, and the
protection of other employees from an
employee who may threaten their
safety. ' I The purpose of finding a "fit"
with an employee is to increase the
employer's economic efficiency. As a
result, employers are rationally drawn
to tests that identify individuals who
would provide the greatest economic
gains to the employer. However, use of
genetic testing in this manner must
operate within certain parameters or
the potential for abuse can be devastating to both employer and employee.
It has been suggested that the freemarket will prevent employers from
conducting genetic screening tests on
employees in an irrational manner. 2
Because of the threat of product liability suits against the manufacturers, the
free market will insure reliable and
accurate genetic screening tests. Placing confidence in the free-market to
protect workers from irrational genetic

testing by employers is tenuous at best.
Some critics claim that if genetic screening tests are accessible to employers at
minimal cost, employers will use them
regardless of their reliability or validity. Currently, some employers use
employment tests that have not been
validated. 3
Many employers believe that genetic screening should be used in connection with the evaluation of a potential employee's job performance. For
example, an employer may use genetic
screening to determine if an employee's
genetic make-up will make him more
susceptible to dying young. If the
employee tests positive and a promotion involves high training expenditures on the employer's part, it makes
economic sense for the employer to
seek another for the promotion. 4 Obviously, society must decide whether
this is an appropriate use of genetic
screening in the workplace. The use of
genetic screening for such purposes
undermines one of society's core values that individuals should be judged
on their merits.
There is a limited role for genetic
screening in the workplace provided
that such testing is conducted under
specific circumstances guaranteed to
prevent arbitrary discrimination against
workers. The American Medical Association ("AMA") has proposed the
"minimum" criteria that would allow
genetic screening to be beneficial to
both employer and employee as consumers. Criteria include the informed
consent of the employee and the use of
highly accurate, sensitive, and specific
tests. The abnormalities tested for
must occur with high frequency in the
occupational setting. Further, the disease must be so serious, irreversible,
and develop so rapidly that other examinations would not be effective in its
prevention."
The proposed criteria for genetic
screening provide a basic framework to
protect employees from unnecessary
genetic screening. The use of genetic
screening in the workplace should only
occur under unusual circumstances and
Loyola Consumer Law Reporter

Lea

I

then only with empirical data to support the claim that genetic abnormalities are occurring as a result of the
workplace.
The criteria focus on placing a duty
upon the employers to provide a safe
workplace for employees. Employers
currently have a duty under common
law to provide safe working conditions
to employees. 6 More importantly,
focusing on workplace safety not only
protects the genetically susceptible
employee but protects the employer
from employee liability. The criteria
mandate that a genetic screening test be
an accurate diagnostic and prognostic
indicator for a specific type of genetic
abnormality. Currently, genetic technology cannot produce a reliable and
accurate genetic screening test, which
fortuitously will prevent many employers from using genetic screening.
Although, the criteria only allows
genetic screening when an employee
has been fully informed of the purpose
of the screening, the AMA's criteria do
not indicate what constitutes informed
consent in this context. For example,
when is an employee fully informed of
the risks and consequences of taking a
genetic screening test? Does the
employee's informed consent apply to
his children and heirs who may be
affected by the screening? The AMA's
guidelines on genetic screening in the
workplace provide a rudimentary foundation from which legislators can draft
legislation to protect employers and
employees from unnecessary genetic
screening.
IV.THE ROLE OF
GOVERNMENT IN GENETIC
SCREENING
The introduction of a new technology to society usually outpaces the
ability of federal, state, and local governments to create legal rules and policies to address the issues generated by
the technology. Currently, there is a
very limited body of law and policy
dealing specifically with genetic screening in the workplace. However, there
is a substantial body of law that has
Volume 5 Number 1 /Fall 1992

developed regarding medical testing in
the workplace. Most likely, the law
will continue to develop in the area of
genetic screening as it grows out of
established rules and policies. 7 For
now, the question is whether those
rules and policies that regulate genetic
screening drawn from medical testing
laws are appropriate.
Some analogies from medical testing in the workplace will be helpful in
creating policies regulating genetic

The AMA 'sguidelineson genetic
screening in the workplace provide a
rudimentary foundation from which
legislators can draft legislation to
protect employers and employees
from unnecessary genetic screening.

screening; however, relying primarily
on this body of law to regulate genetic
screening is unwise. Since genetic
screening is such a new and dynamic
technology, with incredible benefits
and drawbacks, legislators must solicit
public participation in the form of
public forums and town hall meetings.
These public forums would allow government to address the concerns of the
public but would also assist in educating the public about the use and interpretation of genetic screening."
Government will experience difficulties in implementing a clear policy
on genetic screening due to continuous
sharp debate over the best method of
implementation. Additionally, the information base for making policy decisions will be in a constant state of
change due to continual genetic advances.59 For these reasons, a uniform
national policy may not be the best first
step in regulating genetic screening.
Furthermore, it would be difficult to
monitor a national uniform policy since
there exists no other policy standard for
comparison purposes.'
It is suggested that the federal gov-
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eminent allow state and local governments to first implement their policies
concerning genetic screening. These
diverse policy experiments would allow the federal government to compare
and choose which policies provide optimal results in regulating genetic
screening. 6 Of course, there may be
negative implications associated with a
delay in the implementation of a uniform national policy on genetic screening. Nevertheless, too often the federal
government hastily implements policies which later prove to be ineffective
and inefficient.
The formation of a governmental
commission assigned to the task of
proposing a model uniform code would
assist state and local governments significantly in their implementation of
genetic screening policies. Within the
legal profession, there are several model
codes for such subjects as criminal,
probate, and tort law. These model
codes have influenced legislation on a
local and national basis. The use of
such a commission along with a comparison of the various governmental
genetic screening policies could lead to
the development of a uniform national
policy providing beneficial regulation
for consumers.
V. LEGAL REMEDIES FOR
GENETIC DISCRIMINATION
Genetic discrimination is as damaging and unjust as discrimination based
on race, gender, religion, or disability.
Genetic discrimination is harmful not
merely because it violates the basic
societal tenets of equality and justice,
treating an individual inequitably solely
because of predetermined characteristics, but because it also hinders an
individual's productivity and ingenuity. Genetic discrimination not only
hurts the excluded individual, but it
steals from the marketplace necessary
skills, energy, and imagination to promote a vital economy. Excluding individuals from society based on their
genetics causes physical, emotional,
and economic dependency, draining
rather than enriching society as a
17
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whole. 62 Allowing genetic discrimina-

tion to exclude any individual from
society is too costly a price for this
nation.
Three sources of disability law have
emerged as the principal weapons
against genetic discrimination: (1) Title
VII of the Civil Rights Act of 1964; (2)
the Rehabilitation Act of 1973; and (3)
the Americans with Disabilities Act of
1990.63

The key to determining the

merit of a legal defense against genetic
discrimination is whether the classification based upon genetic characteristics falls into the categories of race,
gender, or disability, or the categories
of sexual orientation, personality, and
intelligence.' A brief review of each
act will show the possible defenses
against genetic discrimination.
A. Title VII of the Civil Rights Act
of 1964
Title VII prohibits discrimination in
hiring on the basis of an individual's
race, sex, color, religion, or national
origin.6' Many genetic abnormalities
are tied to race, national origin, and
sex; thus, if an employer denies an
applicant employment due to genetic
factors that fall within these protected
categories, the applicant may raise a
Title VII claim. 66 The applicant must

show that the use of genetic screening
was merely a pretext for discrimination
against a protected class.67
Employers subject to the Act are
those with fifteen or more employees,
labor organizations, employment agencies, and state or municipal governments.68 If an applicant can clear the
threshold requirements of the Act, a
plaintiff can bring discrimination claims
under disparate treatment and disparate
impact theories. In a disparate treatment suit, the plaintiff must allege that
the employer discriminated against him
because of race, sex, or some other
immutable characteristic.' Additionally, the plaintiff must show the
employer's discriminatory intent; if
the plaintiff cannot, he loses.70 In a
disparate impact case, the plaintiff must
prove that a facially neutral test (ge18

netic screening) disproportionately disqualified a protected class from employment. The plaintiff is not required
to prove that the employer had discriminatory motives.7
After a plaintiff has shown disparate
impact, the employer has the burden of
justifying the genetic screening process
as a legitimate job requirement or business necessity.72 The employer must
demonstrate that: (1) the business purpose for genetic screening is suffi-

Genetic discrimination is harmful
not merely because it violates the
basic societal tenets of equality and
justice, treating an individual
inequitably solely because of
predetermined characteristics, but
because it also hinders an
individual's productivity and
ingenuity.

ciently compelling to override any discriminatory effect; (2) the genetic
screening is necessary to carry out the
employer's business purpose; and (3)
genetic screening is the least discriminatory alternative to accomplish the
business purpose without increased
cost.

73

A successful disparate defense allows an employer to lawfully discriminate against an individual due to his
immutable characteristics because the
immutable characteristics truly prevent
the individual from properly doing the
job. The determination of whether
genetic screening in the workplace is a
business necessity is left to the courts,
due to the complex legal issues of
genetic screening in the workplace.
Moreover, a shortcoming of Title VII
is that it is not an effective defense
against genetic discrimination when an
individual's atypical make-up does not
fall into one of Title VII's protected
classes.

B. The Rehabilitation Act of 1973
The Rehabilitation Act specifically
prohibits discrimination against handicapped individuals regardless of membership in any protected racial, religious, or ethnic group.7 4 The purpose
of the Act is to allow individuals with
disabilities to "maximize their employability, independence, and integration
into the workplace and the community.

' 75

The Act is limited in its appli-

cation to those entities and institutions
that receive federal assistance or government contracts.
For the Rehabilitation Act to apply
to genetic screening, the courts would
first have to determine whether a genetic abnormality or predisposition to a
genetic illness is a disability. A disabled person is defined as: "any person
who (i) has a physical or mental impairment which substantially limits one
or more of such person's major life
activities, (ii) has a record of such
impairment, or (iii) is regarded as hav76
ing such an impairment.

The Supreme Court in SchoolBoard
of Nassau County v. Arline77 defined a
"handicapped" person as one not only
physically impaired, but also one perceived to be impaired and who, as a
result, is substantially limited in a major life activity. It can be concluded
from Arline that individuals who possess genetic abnormalities or are perceived to possess genetic abnormalities
can be considered handicapped or disabled.
After determining that an individual
is susceptible to a genetic illness and is
considered disabled under the Act, a
court must determine if the individual
is qualified to perform the essential
functions of the job in question. Generally, a determination of whether a
person is qualified for a job requires a
separate investigation based on reasonable medical judgments.7"
Finally, the disabled person could
be qualified for the job in question if
the employer makes reasonable accommodations for the individual. The
courts will determine the extent to
which an employer must make accomLoyola Consumer Law Reporter
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modations for a disabled individual to
perform his job. Notably, undue financial burden on the employer relieves
the employer from accommodating the
disabled individual.79
There are several shortcomings in
the application of the Rehabilitation
Act to genetic discrimination. The Act
is limited to only those institutions that
receive federal monies. Potential plaintiffs cannot sue their employers directly under the Act.80 Moreover, the
Act requires that a court determine first
if a genetic predisposition is a disability and second, if the disabled individual is qualified for the job. These
types of determinations are best made
by Congress and not the courts because
courts have great difficulty in resolving technological issues and implementing those resolutions into public policy.8
C. The Americans With Disabilities
Act of 1990
The Americans with Disabilities Act
of 199082 (ADA) is the most sweeping
civil rights reform since the Civil Rights
Act of 1964.13 The ADA, in contrast to
the Rehabilitation Act of 1973, provides comprehensive anti-discrimination protection to individuals with disabilities in private sector employment,
public services, public accommoda84
tions, and telecommunications.
The definition of disability under
the ADA is broadly defined to mean:
(A) "a physical or mental impairment
that substantially limits one or more
major life activities, . . . (B) a record

of such impairment, or (C) being perceived as having such an impairment." 85
Congress purposely adopted a broad
definition that protects individuals from
discrimination who are perceived as
disabled because of society's myths,
fears, or stereotypes 8. 6 Therefore, most
genetic defects and perceived susceptibility to genetic disease are covered
under the ADA's definition of disability.
The ADA parallels the Rehabilitation Act of 1973 regarding the elements required to establish a prima
facie case of discrimination.87 The
Volume 5 Number 1 /Fall 1992

individual must show that he: (1) comes
under the disability definition; (2) is
qualified for the questioned position;
or (3) would be qualified if the employer makes reasonable accommodations. The ADA defines "qualified" as
the individual's ability to perform the
essential tasks of employment at the
time of the application.88 The possibility that an individual may become unqualified at some future point does not
justify discrimination. It should be
noted that the ADA allows each individual employer to determine what
operations of a job are essential.89
Reasonable accommodation under
the ADA imposes an affirmative duty
upon employers to make the workplace
environment accessible and reduce any
significant risks to the health and safety
of the disabled individual.' However,
an employer is not required to make
reasonable accommodations if it would
impose an undue financial hardship on
the operations of the business. More-

tied to race, national origin, and

I sex.
Manygenetic abnormalities are

over, the reasonable accommodations
do not include changes that fundamentally alter the nature of the business.
The ADA also prohibits employers
from conducting pre-offer medical
examinations to determine a job
applicant's disabilities. 91 However, an
employer can conduct a medical examination of job applicants if a conditional offer of employment has been
extended and the examination is strictly
related to the applicant's ability to
perform the job.' If a job applicant
fails the medical examination, then the
employer may exclude the applicant
from employment. Therefore, employers must have a compelling jobrelated reason to use genetic screening
in the workplace.

Under the ADA, employers are allowed to discriminate against disabled
individuals if there is a direct threat to
the health and safety of other employees in the workplace.93 The employer
must identify the specific risk the disabled individual poses to others in the
workplace. Risks based upon irrational
fears, generalizations, or patronizing
attitudes are not acceptable.
For many reasons, the ADA provides the most powerful weapon, to
date, for the prevention of genetic discrimination. First, there is a broad
definition for disability which includes
perceived disabilities. Second, employers must provide reasonable accommodations to the disabled. Third,
employers using the available ADA
defenses have several factual and legal
hurdles to clear before these defenses
are viable. Finally, genetic screening is
restricted to employers who can show a
substantial job-related reason for its
use.
CONCLUSION
Presently, genetic screening in the
workplace is an unreliable and inaccurate technology for diagnosis and prognostication of individuals susceptible
to genetic disease. However, as the
Human Genome Initiative and private
industry continue to unravel the secrets
of genetics, genetic screening will become a reliable tool and allow consumers to make valid decisions concerning
employment.
Consumers must be actively involved
with government to determine the underlying policies which will regulate
genetic screening in the workplace. At
first, a uniform national policy to regulate genetic screening in the workplace
will not benefit consumers. Allowing
local and state governments to institute
their genetic screening policies before
the federal government's national policy
will allow the federal government and
consumers to decide which policies are
best at regulating screening in the workplace. This comparison approach will
provide a sound basis for society, as a
whole, to pick a uniform national policy
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on genetic screening, if one is required.
Unfortunately, genetic screening in
the workplace will unfairly discriminate against some. Of particular concern are the issues of informed consent
and confidentiality surrounding genetic
screening in the workplace. Comprehensive discussion among consumers
will serve to determine the requirements of informed consent and how
confidentiality will be protected in the
workplace. It is hoped that the AMA's
guidelines for genetic screening in the
workplace will provide a basis from
which consumers can discuss these issues. Finally, consumers need to realize that genetic screening in the workplace will provide unprecedented benefits. Though genetic screening today
may be considered unfit, it is likely that
such testing will become fit to solve
workplace problems in the future that
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